Alation Awarded Snowflake Data Governance Partner of the Year for Second Consecutive Year
Receives five industry competency badges for helping customers easily govern their data
REDWOOD CITY, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Alation Inc., the leader in enterprise data intelligence solutions, today announced it has been named Data Governance Partner of the Year by Snowflake, the Data Cloud company. Snowflake selected Alation to receive this recognition for the second consecutive year and the award was presented on June 13, 2022, at Snowflake Summit in Las Vegas. Alation was also awarded five competency badges in the Snowflake Partner Network (SPN) Competency Program for its work with customers in key industries: financial services, healthcare and life sciences, media and telecommunications, retail and CPG, and technology.
Snowflake recognized Alation for its integral role in Snowflake’s partner ecosystem, helping more than 125 joint customers deliver value in their industries by accelerating migration to the Data Cloud and providing active data governance to drive self-service. Alation’s dedicated features, created for Snowflake, can help increase confidence in data by meeting the challenges of data stewards, scientists, and analysts by enforcing consistent data policies, protecting sensitive data at scale, and providing transparency into the data lifecycle. This simplifies maintaining industry standards and regulatory compliance and ensures everyone can access trusted, compliant data.
“Using Alation alongside Snowflake has enabled a step-change in our data governance capability and visibility of enterprise data for users across Spark NZ,” said Peter Langham, Domain Chapter Lead, Data Engineering at Spark NZ. “It has significantly improved both productivity and quality of insights for our data analysts through a common understanding of our data assets.”
The Snowflake Partner Network Competency Program, unveiled at Snowflake Summit 2022 rewards and validates Snowflake partners, like Alation, for the depth of their Snowflake expertise and commitment to driving customer impact across the Data Cloud ecosystem. Alation has been awarded industry competencies for their Snowflake solutions in the following industries:
- Financial Services: for supporting data-driven innovation, delivering personalized customer experiences, and improving regulatory compliance
- Healthcare and Life Sciences: for helping organizations use data to improve patient outcomes, navigate business model changes, and create better patient experiences
- Media and Telecommunications: for creating a better understanding of audiences and using data to deliver solutions and experiences
- Retail and CPG: for developing multi-channel experiences with access to trusted data, driving innovation, and improving operational and supply chain efficiency
- Technology: for building data-driven products, enabling organizations to better understand customers and improve operations
“Snowflake is the market-leading cloud data company. Being recognized by Snowflake for the second year in a row underscores our ability to provide joint customers with reliable, trusted data governance and drive greater value,” said Satyen Sangani, CEO and co-founder, Alation. “Alation is honored to be named Data Governance Partner of the Year again and receive five industry competencies from Snowflake. It validates our strengths and how we help organizations build data culture. We look forward to driving even greater value for our joint customers in the future.”
“Data governance is important to Snowflake customers, and Alation helps organizations mitigate compliance risk and accelerate productivity across key industries,” said Colleen Kapase, SVP of WW Partner and Alliances at Snowflake. “Alation’s comprehensive governance solution allows joint customers to securely use their data, enabling access to the right data at the right time, while ensuring adherence to privacy and other regulatory requirements and adding value to customers’ Snowflake capabilities.”
The Snowflake and Alation partnership is instrumental in delivering data value for key industries, and today’s news is the latest milestone in Snowflake and Alation’s growing partnership. In April 2021, Alation was one of the first five featured Snowcases — industry and technology solutions by Snowflake's trusted partners to support the Snowflake Data Cloud journey — debuting with its Active Data Governance Capability for Snowflake. In June 2021, Snowflake participated in Alation’s Series D funding round and named Alation its Data Governance Partner of the Year. In September 2021, Alation strengthened its partnership with Snowflake and they were the first companies to achieve assessment under the new Cloud Data Management Capabilities (CDMC) standard, which is sponsored by the EDM Council and verified by KPMG. In November 2021, Alation joined Snowflake’s Data Governance Accelerated Program to further support joint customers on their data governance journeys.
- Connect with Alation at Snowflake Summit through our sessions & activities
- Read the blog, Two Years Running: Alation Is Snowflake's Data Governance Partner of the Year!
- Learn more about Alation’s partnership with Snowflake on our partner page
- Discover the Top 10 Reasons to Choose Alation for Your Snowflake Data Cloud
Alation is the leader in enterprise data intelligence solutions including data search & discovery, data governance, data stewardship, analytics, and digital transformation. Alation’s initial offering dominates the data catalog market. Thanks to its powerful Behavioral Analysis Engine, inbuilt collaboration capabilities, and open interfaces, Alation combines machine learning with human insight to successfully tackle even the most demanding challenges in data and metadata management. More than 350 enterprises drive data culture, improve decision making, and realize business outcomes with Alation including AbbVie, Allianz Global Investors, American Family Insurance, Autozone, Cisco, Draft Kings, Exelon, Fifth Third Bank, Finnair, General Mills, Munich Re, NASDAQ, Parexel, Pfizer, Salesforce, Virgin Australia, and Vistaprint. Headquartered in Silicon Valley, Alation was named to Inc. Magazine’s Best Workplaces list three times and is backed by leading venture capitalists including Blackstone, Costanoa, Data Collective, Dell Technologies, Icon, ISAI Cap, Riverwood, Salesforce, Sanabil, Sapphire, and Snowflake Ventures. For more information, visit alation.com.
Alation Media Contact
Sr. Director of Corporate Marketing
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 202224.6.2022 22:05:00 CEST | Press release
REPORT –ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June24, 2022 – ERYTECH Pharma (Nasdaq& Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcedthat its Annual General Meeting was held on Friday, June 24, 2022. At the meeting, all resolutions for which the Board of Directors recommended a vote in favor were adopted, including: Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2021;Allocation of the financial year's results;Approval of the statutory auditors’ special report on regulated agreements and commitments with related parties;Approval of the elements of total compensation and benefits paid or allocated for the year ended December 31, 2021, to Gil BEYEN, Chief Executive Officer and Jean-Paul KRESS, Chairman of the Board;Approval of the compens
Cleantech Building Materials: Results of Annual General Meeting24.6.2022 14:54:27 CEST | Press release
24 June 2022 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM ISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC Results of Annual General Meeting The Annual General Meeting (“AGM”) of Cleantech Building Materials plc (“CBM” or the “Company”) was held in London earlier today, 24 June 2022. Details of the resolutions to be considered at the AGM were published in the Notice of AGM which was posted to Shareholders on 1 June 2022 and is available on the Company’s website: www.cbm-plc.com. All resolutions as set out in the Notice of AGM were duly passed without discussion. In particular, the following resolutions were passed at the AGM. The AGM resolved to authorise the directors of the Company to allot shares and grant rights to subscribe for, or convert any security, into shares. The directors of the Company sought authority for the purposes of section 551 of the Companies Act to exercise all the powers of the Company to allot shares and grant ri
Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia24.6.2022 13:13:19 CEST | Press release
With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at least two prior tyrosine kinase inhibitor treatments1 Positive opinion based on data from pivotal Phase III ASCEMBL trial, showing a near doubling in major molecular response rate for patients treated with Scemblix® (asciminib) vs. Bosulif®* (bosutinib) (25.5% vs. 13.2%) and more than three times lower discontinuation rate due to adverse reactions (5.8% vs 21.1%) at 24 weeks1 CHMP recommendation comes after the approval of Scemblix by the US FDA and other countries’ regulatory authorities, potentially broadening access for more patients to Novartis transformative therapies in CML Basel, June 24, 2022 — Novartis today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing au
Clariant’s shareholders approve all agenda items24.6.2022 11:30:00 CEST | Press release
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Integrated Report and Group Consolidated Financial Statements for fiscal year 2021 approvedGünter von Au reelected as Chairman of the Board of DirectorsThree new candidates join the Board of Directors: Ahmed Mohamed Alumar, Roberto César Gualdoni, Naveena ShastriConfirmed distribution of CHF 0.40 per shareKPMG confirmed as statutory auditor from 2022 MUTTENZ, JUNE 24, 2022 Clariant, a focused, sustainable, and innovative specialty chemical company, today held its 27th Annual General Meeting (AGM) where the shareholders approved all agenda items and resolutions as proposed by the Board of Directors. The AGM was held virtually, where shareholders were able to exercise their rights exclusively via the independent proxy. Overall, 698'945'298 shares or around 70.19 % of the share capital of Clariant were represented. Günter von Au was reelected as Chairman of the Board of Directors. Additionally, three new members were voted to join by a large majo
Cool Company Ltd. – Mandatory Notification Of Trade24.6.2022 11:01:19 CEST | Press release
EPS Ventures Ltd., close associate of Cyril Ducau, Chair of the Board of Cool Company Ltd. (the “Company”), has on 23 June 2022 acquired 7,865 shares in the Company at a price of NOK 90.274882 per share. Following the transaction, EPS Ventures Ltd. holds a total of 15,591,218 shares in the Company, equivalent to 38.97% of the Company’s shares. Please see the attached notification form in accordance with the Market Abuse Regulation article 19. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Primary insider notification form